Lv4
739 积分 2021-05-16 加入
794-P: MET-097: Preclinical Characterization of a Potent and Ultra-Long-Acting GLP-1 Receptor Agonist
11小时前
求助中
Diagnosis and treatment of Parkinson´s disease (guideline of the German Society for Neurology)
14小时前
待确认
Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation
4天前
已完结
IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease
4天前
已完结
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND Study
5天前
已完结
Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson’s disease: 3-year outcomes from the open-label BeyoND study
5天前
已完结
128 Efficacy and safety of deep brain stimulation in Parkinson’s disease: systematic review and meta-analysis
5天前
已关闭
脑深部电刺激术联合药物治疗帕金森病有效性和安全性的meta分析
5天前
已完结
Efficacy and Safety of Novel Continuous Subcutaneous Levodopa Infusion Therapies ND0612 and ABBV-951 for Parkinson’s Disease: A Systematic Review
13天前
已完结
MBX 2109, a Once-Weekly Parathyroid Hormone Replacement Therapy Prodrug: Phase 1, First-in-Human, Randomized Trial
18天前
已完结
皖公网安备34019202002308
